Big movers on D-Street: What should investors do with IRB Infra, IGL and Dr Reddy's?

Stocks that were in focus include names like IRB Infra, which fell 3%, IGL, which was down 2.48%, and Dr Reddy's, whose shares declined 2.8% on Wednesday.

took a heavy beating with the tumbling 1,062 points on Thursday. Analysts said are trimming their equity exposure at a faster pace as the election season heats up, which can be seen from the drubbing that received.

that were in focus include names like , which fell 3%, , which was down 2.48%, and , whose shares declined 2.8%.

Here's what By Riyank Arora at , recommends investors should do with these stocks when the market resumes trading today.

IRB Infra

The stock has touched its anchor VWAP support mark of 66 on its daily charts. It is expected that the stock should hold well above its major support mark of 63.

So we advise holding on to IRB Infra with a strict stop-loss of 63 on a daily closing basis for potential upside targets of 73 and 79. With the RSI (14) on daily charts witnessing a minor uptick, it is expected that the stock should pick up good momentum in the upcoming few trading sessions.

IGL

The stock went up nearly 8% in Wednesday's session but later faced profit booking at higher levels, ending close to 3% higher for the day.

At present levels of 451, the stock has an immediate major support at the 425 mark, and an immediate resistance is placed near the 470 mark.

Overall, we expect the stock to remain sideways and face supply at higher levels and demand at lower levels, staying within the range of 425 - 470 for the week.

Dr Reddy's

The stock is trading well above its major support mark of 5880.00 on the daily charts. With the base trend being positive and the stock making higher highs and higher lows, and the RSI (14) on daily charts being around 43, momentum looks low.

It is expected that the stock should hold well above its support mark. We advise a strict stop-loss at 5880 on a daily closing basis for Dr Reddy, for potential targets of 6200 and 6400.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Source: Stocks-Markets-Economic Times

Останні публікації
Nestle to cut costs by $2.8 billion, boost marketing under CEO Freixe
19.11.2024 - 11:00
Elbit Systems earnings beat by $0.49, revenue topped estimates
19.11.2024 - 11:00
Rothschild opens wealth management office in Dubai to tap wealth influx
19.11.2024 - 11:00
Nvidia to report solid earnings beat but near-term upside limited, KeyBanc says
19.11.2024 - 11:00
RBC initiates Tesco at 'sector perform', Sainsbury's at 'outperform'
19.11.2024 - 11:00
Safe-haven assets rally after Russia updates nuclear doctrine
19.11.2024 - 11:00
Rheinmetall aims for 20 billion euros in sales in 2027
19.11.2024 - 11:00
Imperial Brands shares rise on strong revenue, NGP growth beats expectations
19.11.2024 - 11:00
Meta to appeal Indian order that curbs data-sharing between WhatsApp, other apps
19.11.2024 - 11:00
XPeng forecasts quarterly revenue above estimates
19.11.2024 - 11:00
European markets open mixed; Crude oil retreats after initial gains
19.11.2024 - 10:00
Goldman Sachs forecasts S&P 500 to hit 6,500 by 2025 end, joining Morgan Stanley
19.11.2024 - 10:00
Bayer acquires rights to Cytokinetics' heart drug in Japan
19.11.2024 - 10:00
Nestle to cut $2.8 billion of costs by 2027, boost marketing under CEO Freixe
19.11.2024 - 10:00
Miners, real estate lead gains in European shares
19.11.2024 - 10:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?